Reportlinker Adds Asthma/COPD in Australia Market Forecast

NEW YORK, June 10 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Asthma/COPD in Australia Market Forecast


The Australian asthma/COPD market grew from $278m in 2006 to $333m in 2009. Its growth will slow considerably with the market projected to reach revenues of $354m in 2019. As new drugs launched will be me-too products or combinations of existing classes, Datamonitor assumes that these will be priced similarly to current brands in order to receive reimbursement, leading to a stabilizing market.

Reasons to Purchase

*Identify opportunities and threats that will impact the Australian asthma/COPD market as a whole and key brands and pipeline products in particular.

*Quantify the future size and Scope of the Australian asthma/COPD market and predict the performance of its key compounds.

*Understand critical success factors in growing and defending asthma/COPD brand franchises from new entrants and generics.

To order this report:

Drug and Medication Industry: Asthma/COPD in Australia Market Forecast

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg


Email: [email protected]

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker